eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Prospective Grant of an Exclusive License: Development and Commercialization of Therapeutic Products for Autoimmune Diseases Including Rheumatoid Arthritis (RA), Inflammatory Bowel Disease (IBD) and Psoriasis

Prospective Grant of an Exclusive License: Development and Commercialization of Therapeutic Products for Autoimmune Diseases Including Rheumatoid Arthritis (RA), Inflammatory Bowel Disease (IBD) and Psoriasis

Document ID: NIH-2006-1012-0001
Document Type: Notice
Agency: National Institutes Of Health
Topics: No Topics associated with this document
Federal Register Number: E6-16526
View Document:  View as format pdf View as format html

Details Information

Received Date: October 06 2006, at 07:08 AM Eastern Daylight Time
Start-End Page: 59125 - 59126
Page Count: 2
Comment Start Date: October 6 2006, at 12:00 AM Eastern Standard Time

Comments

Total: 0
No comments posted.

Related Documents

Total: 0
No documents available.